Canada markets closed

Viracta Therapeutics, Inc. (VIRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.8102-0.0298 (-3.55%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
26,862
33,369
26,262
23,861
13,467
Selling General and Administrative
23,471
17,324
24,327
15,437
5,348
Total Operating Expenses
50,333
50,693
50,589
25,798
18,815
Operating Income or Loss
-50,333
-50,693
-50,589
-25,798
-18,815
Interest Expense
529
3,704
577
491
216
Total Other Income/Expenses Net
-6
-6
798
-88,511
-34
Income Before Tax
-50,318
-51,058
-49,197
-114,762
-19,017
Income from Continuing Operations
-50,318
-51,058
-49,197
-114,762
-19,017
Net Income
-50,318
-51,058
-49,197
-114,762
-19,017
Net Income available to common shareholders
-50,318
-51,058
-49,197
-114,762
-19,017
Basic EPS
-1.24
-1.32
-1.30
-3.60
-0.51
Diluted EPS
-1.24
-1.32
-1.30
-3.60
-0.51
Basic Average Shares
38,507
38,624
37,791
31,870
36,995
Diluted Average Shares
38,507
38,624
37,791
31,870
36,995